{"schema_version":"1","generated_at":"2026-11-02T07:44:32.166Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sepehr-rokhsar","json_url":"https://www.findmykol.com/kol/sepehr-rokhsar/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sepehr-rokhsar","name":"Sepehr Rokhsar","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cedars-Sinai Medical Center","institution_url":"https://www.findmykol.com/institution/cedars-sinai-medical-center","city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1437182805","openalex":"A5000002459"},"summary":"Sepehr Rokhsar is an Oncology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 8 publications with 549 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":8,"cited_by_count":549,"h_index":6,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Incyte Corporation","program_year":2025,"amount_usd":29683.18,"payment_count":30,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437182805"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":6493.01,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437182805"},{"payer":"BeOne Medicines USA, Inc.","program_year":2025,"amount_usd":106.29,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437182805"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1437182805","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":46.2,"classes_total":6,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":17.7,"drugs":[{"name":"Jakafi","share_pct":34.7},{"name":"Calquence","share_pct":28.8},{"name":"Jaypirca","share_pct":12.7},{"name":"Brukinsa","share_pct":11.9},{"name":"Imbruvica","share_pct":11.9}],"max_beneficiaries":null},{"class":"Antimetabolite","setting":"prescribed","share_pct":10.9,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":14}]},{"area":"Musculoskeletal","share_pct":24,"classes_total":1,"classes":[{"class":"Bisphosphonate","setting":"administered","share_pct":24,"drugs":[{"name":"Zoledronic acid","share_pct":100}],"max_beneficiaries":32}]},{"area":"Blood & clotting","share_pct":13.8,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":12.1,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":15},{"class":"Other systemic hemostatics","setting":"prescribed","share_pct":1.6,"drugs":[{"name":"Doptelet","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":87,"facility_pct":13},"source":"medicare"},"publications":{"total":8,"shown":5,"withheld":3,"matched_by":"OpenAlex author record","recent":[{"title":"A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer","year":2019,"journal":"EBioMedicine","source_url":"https://doi.org/10.1016/j.ebiom.2018.12.060","status":"verified"},{"title":"First-in-Human Phase 1 Study of Veliparib, a PARP-1/2 Inhibitor, with Gemcitabine and Radiotherapy in Locally Advanced Pancreatic Cancer","year":2018,"journal":"SSRN Electronic Journal","status":"verified"},{"title":"Phase I study of veliparib with gemcitabine and radiation therapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer.","year":2016,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2016.34.4_suppl.tps487","status":"verified"},{"title":"Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas","year":2015,"journal":"Leukemia Research","source_url":"https://doi.org/10.1016/j.leukres.2015.04.003","status":"verified"},{"title":"Intestinal stoma complications in immunocompromised children","year":1999,"journal":"Journal of Pediatric Surgery","source_url":"https://doi.org/10.1016/s0022-3468(99)90306-8","status":"verified"}],"source":"works"},"contact":{"address_1":"CEDARS-SINAI OUTPATIENT CANCER CENTER","address_2":"8700 BEVERLY BLVD.","city":"Los Angeles","state":"CA","zip":"90048","phone":"310-423-0301","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1437182805","source":"identity"},"similar":[{"name":"Raj Makkar","slug":"raj-makkar","institution":"Cedars-Sinai Medical Center","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/raj-makkar","json_url":"https://www.findmykol.com/kol/raj-makkar/profile.json"},{"name":"Eduardo Marban","slug":"eduardo-marban","institution":"Cedars-Sinai Medical Center","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/eduardo-marban","json_url":"https://www.findmykol.com/kol/eduardo-marban/profile.json"},{"name":"Stephen Freedland","slug":"stephen-freedland","institution":"Cedars-Sinai Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/stephen-freedland","json_url":"https://www.findmykol.com/kol/stephen-freedland/profile.json"},{"name":"Jon Kobashigawa","slug":"jon-kobashigawa","institution":"Cedars-Sinai Medical Center","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/jon-kobashigawa","json_url":"https://www.findmykol.com/kol/jon-kobashigawa/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":3}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}